Collegium Pharma (COLL) Misses Q1 EPS by $1.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Collegium Reports First Quarter 2022 Financial Results
May 10, 2022 4:01 PM EDT- Generated Net Revenue of $83.8 Million -
- Completed BDSI Acquisition; On Track to Exceed Targeted Run Rate Synergies of at Least $75 Million -
- Resolved All Opioid-Industry Litigation -
- Reaffirms 2022 Financial Guidance -
- Conference Call Scheduled for Today at 4:30 p.m. ET -
STOUGHTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) --... More
